SFA Therapeutics developing its psoriasis therapy to showcase its anti-inflammatory platform

preview_player
Показать описание
SFA Therapeutics, Inc CEO Dr. Ira Spector sat down with Proactive at the BIO Investor Forum in San Francisco. The Pennsylvania-based company, using microbiome-derived metabolites as drugs, is advancing its oral treatment for psoriasis into Phase 2 clinical studies.
Рекомендации по теме